480 related articles for article (PubMed ID: 19023372)
1. [Drug resistance in tuberculosis].
Winje BA; Mannsåker T; Langeland N; Heldal E
Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2588-92. PubMed ID: 19023372
[TBL] [Abstract][Full Text] [Related]
2. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study].
Yoshiyama T; Ogata H; Ito K; Aono A; Wada M
Kekkaku; 2007 Feb; 82(2):95-101. PubMed ID: 17373318
[TBL] [Abstract][Full Text] [Related]
3. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.
Pablos-Mendez A; Gowda DK; Frieden TR
Bull World Health Organ; 2002; 80(6):489-95; discussion 495-500. PubMed ID: 12132008
[TBL] [Abstract][Full Text] [Related]
4. Drug-resistant tuberculosis in Cuba. Results of the three global projects.
Montoro E; Lemus D; Echemendía M; Armas L; González-Ochoa E; Llanes MJ; Valdivia JA
Tuberculosis (Edinb); 2006; 86(3-4):319-23. PubMed ID: 16569512
[TBL] [Abstract][Full Text] [Related]
5. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2006 Mar; 55(11):301-5. PubMed ID: 16557213
[TBL] [Abstract][Full Text] [Related]
6. Likelihood of generating MDR-TB and XDR-TB under adequate National Tuberculosis Control Programme implementation.
Caminero JA
Int J Tuberc Lung Dis; 2008 Aug; 12(8):869-77. PubMed ID: 18647445
[TBL] [Abstract][Full Text] [Related]
7. Multidrug-resistant tuberculosis (MDR-TB) in India: an attempt to link biosocial determinants.
Atre SR; Mistry NF
J Public Health Policy; 2005 Apr; 26(1):96-114. PubMed ID: 15906879
[TBL] [Abstract][Full Text] [Related]
8. Tuberculosis recurrence and mortality after successful treatment: impact of drug resistance.
Cox H; Kebede Y; Allamuratova S; Ismailov G; Davletmuratova Z; Byrnes G; Stone C; Niemann S; Rüsch-Gerdes S; Blok L; Doshetov D
PLoS Med; 2006 Oct; 3(10):e384. PubMed ID: 17020405
[TBL] [Abstract][Full Text] [Related]
9. [Risk of acquisition of RFP resistance out of INH resistant RFP susceptible tuberculosis].
Yoshiyama T; Ito K; Ogata H; Aono A; Wada M
Kekkaku; 2005 Jan; 80(1):9-14. PubMed ID: 15839057
[TBL] [Abstract][Full Text] [Related]
10. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
[TBL] [Abstract][Full Text] [Related]
11. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
[TBL] [Abstract][Full Text] [Related]
12. [Surveillance of Mycobacterium tuberculosis resistance to antituberculosis drugs].
Garzón MC; Angée DY; Llerena C; Orjuela DL; Victoria JE
Biomedica; 2008 Sep; 28(3):319-26. PubMed ID: 19034356
[TBL] [Abstract][Full Text] [Related]
13. [Emergence extensive drug resistance tuberculosis (XDR)].
Vier H; Schaberg T; Gillissen A
Pneumologie; 2007 Sep; 61(9):606-9. PubMed ID: 17729211
[TBL] [Abstract][Full Text] [Related]
14. [Epidemiological survey on the trend of drug resistance of Mycobacterium tuberculosis complex in Macao during 2001 to 2005].
Cheong SV; Lao UL
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):411-4. PubMed ID: 17673010
[TBL] [Abstract][Full Text] [Related]
15. Management of multidrug-resistant tuberculosis: Update 2007.
Yew WW; Leung CC
Respirology; 2008 Jan; 13(1):21-46. PubMed ID: 18197909
[TBL] [Abstract][Full Text] [Related]
16. Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring tool.
Migliori GB; Sotgiu G; Jaramillo E; Mirzayev F; Centis R; Colvin C; Richardson MD
Int J Tuberc Lung Dis; 2009 Oct; 13(10):1305-8. PubMed ID: 19793438
[TBL] [Abstract][Full Text] [Related]
17. Worldwide emergence of extensively drug-resistant tuberculosis.
Shah NS; Wright A; Bai GH; Barrera L; Boulahbal F; Martín-Casabona N; Drobniewski F; Gilpin C; Havelková M; Lepe R; Lumb R; Metchock B; Portaels F; Rodrigues MF; Rüsch-Gerdes S; Van Deun A; Vincent V; Laserson K; Wells C; Cegielski JP
Emerg Infect Dis; 2007 Mar; 13(3):380-7. PubMed ID: 17552090
[TBL] [Abstract][Full Text] [Related]
18. Drug-resistant tuberculosis--current dilemmas, unanswered questions, challenges, and priority needs.
Zumla A; Abubakar I; Raviglione M; Hoelscher M; Ditiu L; McHugh TD; Squire SB; Cox H; Ford N; McNerney R; Marais B; Grobusch M; Lawn SD; Migliori GB; Mwaba P; O'Grady J; Pletschette M; Ramsay A; Chakaya J; Schito M; Swaminathan S; Memish Z; Maeurer M; Atun R
J Infect Dis; 2012 May; 205 Suppl 2():S228-40. PubMed ID: 22476720
[TBL] [Abstract][Full Text] [Related]
19. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
[TBL] [Abstract][Full Text] [Related]
20. Two simultaneous outbreaks of multidrug-resistant tuberculosis--Federated States of Micronesia, 2007-2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Mar; 58(10):253-6. PubMed ID: 19300407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
